Recurrent Pregnancy Loss Clinical Trials

8 recruitingLast updated: May 5, 2026

There are 12 actively recruiting recurrent pregnancy loss clinical trials across 7 countries. Studies span Not Applicable, Phase 4. Top locations include Shenyang, Liaoning, China, Austin, Texas, United States, Baltimore, Maryland, United States. Updated daily from ClinicalTrials.gov.


Recurrent Pregnancy Loss Trials at a Glance

12 actively recruiting trials for recurrent pregnancy loss are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Shenyang, Austin, and Baltimore. Lead sponsors running recurrent pregnancy loss studies include Shenyang Medical College, Leiden University Medical Center, and Hospital de Clinicas de Porto Alegre.

Browse recurrent pregnancy loss trials by phase

Treatments under study

About Recurrent Pregnancy Loss Clinical Trials

Looking for clinical trials for Recurrent Pregnancy Loss? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Recurrent Pregnancy Loss trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Recurrent Pregnancy Loss clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting

DLPFC and Sympathetic Reactivity in RPL With Anxiety

Anxiety DisorderRecurrent Pregnancy Loss Without Current Pregnancy
Shenyang Medical College50 enrolled2 locationsNCT07045818
Recruiting
Not Applicable

Cardiac Autonomic and Anxiety Regulation Via Closed-loop nEurofeedback in Recurrent Pregnancy Loss

AnxietyRecurrent Pregnancy Loss
Shenyang Medical College62 enrolled2 locationsNCT07325370
Recruiting
Not Applicable

High-Intensity, Low-Frequency Periodic rTMS Over the Right Dorsolateral Prefrontal Cortex on Cardiac Autonomic Regulation in Women With Recurrent Pregnancy Loss and Anxiety

AnxietyRecurrent Pregnancy Loss(RPL)
Shenyang Medical College46 enrolled2 locationsNCT07233278
Recruiting
Not Applicable

Tender Loving Care for Recurrent Pregnancy Loss

Recurrent Pregnancy Loss
Walter Reed National Military Medical Center60 enrolled1 locationNCT06182878
Recruiting
Not Applicable

High-Intensity, Low-Frequency Periodic rTMS Over the Right Dorsolateral Prefrontal Cortex on Cardiac Autonomic Regulation in Women With Recurrent Pregnancy Loss and Anxiety

Anxiety DisordersRecurrent Pregnancy Loss
Shenyang Jinghua Hospital55 enrolled3 locationsNCT06968026
Recruiting

Genomic Predictors of Recurrent Pregnancy Loss

Recurrent Pregnancy Loss
Yale University500 enrolled10 locationsNCT05444283
Recruiting

Association Between Plasma Level of Mannose Binding Lectin and Human Reproduction

Recurrent miscarriageRecurrent implantation failureMannose binding lectin deficiency+4 more
Aalborg University Hospital500 enrolled1 locationNCT05169541
Recruiting

Uterine Microbiome in Recurrent Pregnancy Loss

Vaginal MicrobiomeRecurrent Pregnancy Loss, Not Pregnant
Mỹ Đức Hospital100 enrolled2 locationsNCT05510622
Recruiting
Not Applicable

Effect of HCQ Combined With LT4 on LBR in Euthyroid Women With URPL and TPO-Ab

Recurrent Pregnancy LossEuthyroid With Thyroid Antibodies
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University796 enrolled2 locationsNCT06652113
Recruiting

Prospective Recurrent Pregnancy Loss Registry

Recurrent Pregnancy Loss
University of British Columbia3,000 enrolled1 locationNCT05989178
Recruiting

Genomics and Microbiome Investigation in Cases of Recurrent Pregnancy Losses

Recurrent Pregnancy Loss(RPL)
Hospital de Clinicas de Porto Alegre20 enrolled1 locationNCT06604338
Recruiting
Phase 4

Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages

Recurrent miscarriageMiscarriageFertility Disorders+2 more
Leiden University Medical Center490 enrolled1 locationNCT05725512